Cancer Research is Not a Line Item. It is a Lifeline – LUNGevity Foundation
LUNGevity Foundation posted on LinkedIn:
“Cancer research is not a line item. It is a lifeline.
In this special edition of the AACI Commentary, leaders from national cancer organizations — representing patients impacted by breast, colorectal, lung, pancreatic, and prostate cancers — join AACI to underscore the critical importance of sustaining cancer research funding for our nation’s cancer centers.
It is authored by:
Courtney Bugler, CFRE, President and CEO of ZERO Prostate Cancer
Anjee Davis, CEO of Fight Colorectal Cancer
Andrea Ferris, President and CEO of LUNGevity Foundation
Julie Fleshman, President and CEO of Pancreatic Cancer Action Network
Jennifer W. Pegher, Executive Director of AACI (Association of American Cancer Institutes)
Victoria Wolodzko Smart, Senior Vice President of Mission Susan G. Komen.
For more than five decades, federal investments in cancer research have helped transform what was once a terminal diagnosis into a survivable disease for millions of Americans. Today, more than 18 million people in the United States are cancer survivors – nearly six times as many as when the National Cancer Act was signed in 1971.
This extraordinary progress is a testament to what is possible when research is prioritized, and patients are at the center of innovation. However, our work is not done. Millions of Americans are still being diagnosed with and dying from cancer each year.
The investments that drive progress are now at grave risk.
Read the special co-authored AACI Commentary.”
More posts featuring LUNGevity Foundation on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023